Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
APApollo Endosurgery, Inc. logo

Apollo Endosurgery, Inc. (APEN)

NASDAQ Global Market · Currency in USD
$10.00 ▲ +0.00 (+0.00%)
At close: Apr 3, 4:00 PM ET. Market closed.

Summary

Previous Close
$10.00
Open
$9.93
Day's Range
$9.92 – $10.00
52 Week Range
$3.49 – $10.30
Volume
1,639,528
Avg. Volume
1,329,953
Market Cap
$579.72M
Beta (5Y Monthly)
2.32
PE Ratio (TTM)
--
EPS (TTM)
-$0.98
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$9.50

Profile: Apollo Endosurgery, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
202
CEO
Charles S. McKhann
Website
endura.com

Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximation via a flexible endoscope. The company also features the Orbera intragastric balloon system, available under brands such as Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System.

Earnings

DateEst.Actual
Mar 30, 2023-$0.21$0.23Beat
Nov 1, 2022-$0.23-$0.28Miss
Aug 2, 2022-$0.22-$0.26Miss
May 3, 2022-$0.20-$0.21Miss
Feb 22, 2022-$0.19-$0.27Miss
Nov 1, 2021-$0.28-$0.23Beat

Analyst view

Consensus price target
$9.50 ▼ -5.0%
Range $9.00 – $10.00
Rating: Buy
Buy 44% · Hold 44% · Sell 11%

Get free alerts on APEN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.